New York, NY -- (SBWIRE) -- 01/16/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Hercules Offshore, Inc (NASDAQ:HERO), Zogenix, Inc (NASDAQ:ZGNX), JA Solar Holdings Co., Ltd. (ADR) (NASDAQ:JASO), Achillion Pharmaceuticals, Inc (NASDAQ:ACHN)
Hercules Offshore, Inc (NASDAQ:HERO) showed a volume of 2.34 million shares by the end of last trade whereas the average volume of the stock remained 2.64 million shares. The stock opened the session at $5.89 but then moved to $5.88. Hercules Offshore, Inc. (Hercules Offshore) provides shallow-water drilling and marine services to the oil and natural gas exploration and production industry globally. It provides these services to national oil and gas companies, integrated energy companies and independent oil and natural gas operators. As of February 23, 2012, it owned a fleet of 42 jackup rigs,
Is HERO a Solid Investment at These Levels? Read This Report For Details
Zogenix, Inc (NASDAQ:ZGNX) opened the session at $4.45 and closed the session at $4.39. The stock showed a negative performance of -0.68% in previous trading session. Zogenix, Inc. (Zogenix) is a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and pain. The Company’s product Sumavel DosePro offers needle-free subcutaneous administration of sumatriptan for the treatment of migraine and cluster headache in a pre-filled, single-use delivery system.
Has ZGNX Found The Bottom And Ready To Gain Momentum? Find Out Here
JA Solar Holdings Co., Ltd. (ADR) (NASDAQ:JASO) opened the session at $9.37 and closed the session at $9.43. The stock showed a positive performance of 2.61% in previous trading session. The beta of the stock remained 3.26. JA Solar Holdings Co., Ltd. (JA Solar) is engaged in the business of designing, developing, manufacturing and selling solar cell and solar module products. The Company is also engaged in the manufacturing and sales of solar cells. Its principal products are monocrystalline and multicrystalline solar cells and it also manufacture a variety of standard and specialty solar modules.
Why Should Investors Buy JASO After The Recent Gain? Just Go Here and Find Out
Achillion Pharmaceuticals, Inc (NASDAQ:ACHN) the stock advanced 1.08% and finished the session at $3.73. Traded with volume of 2.30 million shares in the prior session and the average volume of the stock remained 2.18 million shares. The beta of the stock remained 0.37. Achillion Pharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of treatments for infectious diseases. The Company is engaged in the development of antivirals for the treatment of chronic hepatitis C infection (HCV), and the development of antibacterials for the treatment of resistant bacterial infections.
Will ACHN Continue To Move Higher? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)